CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Dr. Andrei Moroz, born and raised in Brazil, at the countrys richest state, São Paulo, obtained a B.Sc. degree in Biology [2006, Federal University of São Carlos (UFSCar), São Carlos, SP/Brazil]. After a 6 month period of biotechnology training, enrolled at a M.Sc. degree and earned the M.Sc. title in Medical Biotechnology [2009, State University of São Paulo (UNESP), São Paulo, SP/Brazil], focused at novel bioscaffolds for stem cell culture and cartilage tissue engineering. After this, obtained the Ph.D. degree (Applied Biology Cell and Structural Biology) at the same university, in the year of 2013, being the thesis focused at the modulatory effects of finasteride and fibronectin on prostate cancer cells ability to migrate and invade. Dr. Moroz has published 33 papers in respected journals, has 888 citations and h-index of 18 (Google Scholar). Has experience in applied biotechnology, 2D and 3D cell culture, stem cells, monoclonal antibodies production and prostate cancer research. He is now an assistant professor at the School of Pharmaceutical Sciences, Department of Clinical Analysis - UNESP, Araraquara, SP, Brazil. Was appointed Deputy Editor in Chief for Monoclonal antibodies in Immunodiagnosis and Immunotherapy in 2024. Has been granted around 1 million R$ (reais) for research and development. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Course studies of human pathologies are important for understandingmechanisms, identification of therapeutic targets and possible treatments. Considering thecurrently developed research, one of the problems presented refers to theanimals to be used, since this theme has many scientific ramificationsand ethical. Therefore, the use of alternative animals appears as an alternative for studie…
Prostate cancer (PCa) is the most diagnosed cancer and the second cause of cancer related deaths among men in America and in Western European countries. In Brazil, the number of new cases of PCa estimated for 2018 was 68,220, with an average survival of 24 months in patients who develop the most lethal form of PCa. Its early detection is of fundamental importance and, for this, monoclonal…
Prostate cancer (PCa) is the most common malignancy in men and the second leading cause of male cancer-related deaths in America and in the Western world. In Brazil, the estimated number of new cases was 68.800 for the year of 2014. The most lethal PCa form is the castration resistant prostate cancer (CRPC), for which available treatments grant median survival of 24 months for affected pa…
Cryptococcosis is a serious fungal infection caused by the pathogens Cryptococcus neoformans and Cryptococcus gattii, mainly affecting immunocompromised individuals. Infection occurs by inhalation of yeast spores present in contaminated organic materials (C. neoformans) or tree bark (C. gattii). The main symptoms include cryptococcal meningitis, a condition with a high mortality rate. Cry…
The present postdoctoral project aims to integrate and align the research expertise acquired by the candidate with the continuation of results obtained thus far, incorporating the production of monoclonal antibodies (mAbs) and their humanization abroad. Paracoccidioidomycosis (PCM) is an underreported disease that affects both immunocompetent and immunocompromised patients. Current treatm…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing grants |
| 3 / 2 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 6 / 6 | Completed scholarships in Brazil |
| 12 / 11 | All research grants and scholarships |
| Associated processes | |